CSIMarket
 


Harmony Biosciences Holdings inc   (HRMY)
Other Ticker:  
 

Harmony Biosciences Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Harmony Biosciences Holdings Inc in the forth quarter 2023?
Harmony Biosciences Holdings inc achieved a return on average equity (ROE) of 27.47 % in its forth quarter 2023, which is below Harmony Biosciences Holdings Inc 's average return on equity, which stands at 35.87%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Major Pharmaceutical Preparations industry 10 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 194, from total ROE ranking in the third quarter 2023 at 320.

What is ROE?



Return On Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change 15.93 % 39.97 % 96.8 % 106.54 % -
Y / Y Net Income Change -45.15 % -56.27 % 45.77 % 37.24 % 113.56 %
Net Income (TTM) in Millions 129 151 200 189 181
Return On Equity (TTM) 27.47 % 33.27 % 47.82 % 52.77 % 60.1 %
HRMY's Total Ranking # 194 # 320 # 35 # 51 # 126
Equity (TTM) in Millions 467 481 485 443 403
Seq. Equity Change -2.98 % -0.79 % 9.51 % 9.98 % 17.14 %
Seq. Net Income Change -30.82 % 12.13 % 16.33 % -39.22 % -44.84 %

Return On Equity Company Ranking
Within: No.
Industry # 11
Sector # 34
Overall # 194

Return On Equity Statistics
High Average Low
62.81 %
35.87 %
8.25 %
(Sep 30 2022)   (Sep 30 2021)





HRMY Annual Return On Equity (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020

Total Equity in Millions 467 403 187 97 0
Y / Y Equity Change 15.93 % 115.99 % 91.92 % - -
Net Income in Millions 129 181 35 -37 0
Y / Y Net Income Change -28.99 % 424.52 % - - -
Return On Equity 27.59 % 45.05 % 18.55 % -38.02 % -





Annual Roe Comment
In 2023 ROE decreased compared to the previous year to 27.59 %, due to deterioration of net income.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HRMY's' Return on Equity at Yahoo Finance
HRMY's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for HRMY's Competitors
Return On Equity for Harmony Biosciences Holdings Inc 's Suppliers
Roe for HRMY's Customers




Companies with similar Return On Equity at Dec 31 2023, within Healthcare Sector ROE
Idexx Laboratories Inc  71.66 %
Tenax Therapeutics Inc   65.78 %
Medpace Holdings Inc   63.98 %
Voyager Therapeutics Inc   63.89 %
Enzo Biochem Inc  53.73 %
Lantheus Holdings Inc   52.00 %
Johnson and Johnson  48.95 %
Zoetis Inc   48.81 %
National Research Corporation  47.79 %
Eli Lilly And Company  46.98 %
Enzon Pharmaceuticals inc   46.47 %
Tenet Healthcare Corp  46.41 %
Siga Technologies Inc  44.84 %
Elite Pharmaceuticals Inc   42.39 %
Star Equity Holdings Inc   42.21 %
Abbvie inc   40.00 %
Baxter International Inc   37.77 %
Alpha Tau Medical Ltd   34.52 %
Insulet Corporation  34.43 %
Earth Science Tech Inc   32.33 %
Novartis Ag  31.77 %
Semler Scientific Inc   30.60 %
Protalix Biotherapeutics inc   29.73 %
Escalon Medical Corp   29.02 %
Virios Therapeutics Inc   28.59 %
Chemed Corporation  27.53 %
Harmony Biosciences Holdings inc   27.47 %
Bristol myers Squibb Company  26.26 %
Gilead Sciences Inc   25.80 %
Collegium Pharmaceutical Inc   25.52 %


Date modified: 2024-02-22T17:09:30+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com